CClinicalTrials.gg
RecruitingNCT04905771Updated Jun 7, 2023

Characterizing Follicles From Auto-transplanted Ovarian Tissue

An observational study in Infertility, Female, sponsored by Peter Humaidan. Recruiting at 1 site in Denmark. Open to female participants aged 18 Years to 42 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-06-07.

Sponsored by Peter Humaidan · Observational

From the registry’s dates

  • Primary completion was expected by Feb 2026, 8 months ago, but the record still lists the study as recruiting.
  • Started Feb 2021; still recruiting 5 years 8 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
10
Ages
18 Years to 42 Years
Sex
Female
01

Study summary

The aim of the project is to characterize the hormonal conditions in egg follicles in women who, prior to fertility treatment, have had autotransplanted frozen ovarian tissue for the purpose of fertility preservation.

02

Conditions studied

  • Infertility, Female

Keywords

  • Infertility
03

In context

Infertility

2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.

This study's planned enrollment of 10 is below the median of 200 across 714 observational studies indexed under Infertility.

Browse Infertility studies →

Lead sponsor

Peter Humaidan is the lead sponsor of 16 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 42 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

30 women undergoing fertility treatment who has had frozen and later autotransplanted ovarian tissue for fertility preservation purposes

Inclusion criteria

  • Women aged 18 years or older
  • Has had frozen and later autotransplanted ovarian tissue for fertility preservation purposes
  • Included in fertility treatment with eff retrieval at the Fertility Clinic Regional Hospital Skive
  • Is willing and able to give informed consent

Exclusion criteria

Exclusion Criteria:

  • Patients undergoing fertility treatment but have not received autotransplanted ovarian tissue for fertility preservation purposes
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
10 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Characterize hormone production in follicles from autotransplanted ovarian tissue

    Women undergoing fertility treatment

    Time frame: 5 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 7, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04905771
Lead sponsor
Peter Humaidan
Collaborators
Reproduktionsbiologisk Laboratorium, JMC, Rigshospitalet, København
Responsible party
Peter Humaidan (Professor, Regionshospitalet Viborg, Skive) — Sponsor-investigator
First posted
May 28, 2021
Start date
Feb 1, 2021
Primary completion
Feb 1, 2026 (estimated)
Completion
Feb 1, 2026 (estimated)
Last update
Jun 7, 2023

Study contacts

Peter Humaidan, Professor
Contact
peter.humaidan@midt.rm.dk
+45 78445760

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion